Evolus, Inc.

EOLS

Evolus, Inc.

EOLS

Insider Sentiment (TTM):

Last Purchase:2025-08-15Last Sale:2026-03-20Shares Purchased (TTM):0Shares Sold (TTM):176,304

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:45,351,803Shares Outstanding:65,186,643Institutional Ownership Pct.:69.57%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	45	50	54	44	62	68	87	85	94	97	63	39
Accounts Receivable Net Current	62	52	55	50	48	47	48	45	43	34	31	30
Inventory Net	41	25	27	33	26	10	12	15	13	12	11	18
Prepaid Expense Current	4	5	4	5	5	3	3	3	6	6	6	4
Other Assets Current	15	8	4	3	4	3	1	2	2	2	2	2
Assets Current	168	139	143	135	145	132	151	150	158	150	112	92
Property Plant And Equipment Net	5	5	5	5	4	3	3	2	2	2	2	2
Operating Lease Right Of Use Asset	6	7	7	7	1	7	7	1	5	6	6	6
Intangible Assets Net Excluding Goodwill	46	47	48	49	49	49	49	47	46	47	47	47
Goodwill	21	21	21	21	21	21	21	21	21	21	21	21
Other Assets Noncurrent	2	2	1	2	2	1	1	1	0	0	0	0
Assets	248	221	226	219	229	213	233	230	234	226	189	168
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	44	20	23	23	23	16	9	14	10	11	4	12
Accrued Liabilities Current	38	32	36	30	28	27	41	35	33	25	34	27
Operating Lease Liability Current	3	3	3	2	2	2	2	2	1	1	1	1
Litigation Reserve Current	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities Current	99	68	75	67	64	56	63	61	54	47	48	49
Operating Lease Liability Noncurrent	5	6	6	7	7	6	7	7	5	5	5	5
Contractual Obligation	-	-	-	-	-	33	34	35	35	35	36	39
Secured Long Term Debt	-	-	146	146	145	122	122	121	121	121	120	95
Long Term Debt Noncurrent	157	156	-	-	-	-	-	-	-	-	-	-
Deferred Income Tax Liabilities Net	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities	279	249	249	248	247	220	227	224	214	208	210	187
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Issued	66	66	65	65	65	64	63	63	63	62	58	57
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	649	643	638	633	627	623	616	609	603	591	539	528
Accumulated Other Comprehensive Income Loss Net Of…	-1	-0	-0	-0	-1	-1	-1	-1	-1	-1	-0	-1
Retained Earnings Accumulated Deficit	-680	-672	-661	-661	-645	-628	-609	-603	-583	-572	-559	-547
Stockholders Equity	-31	-29	-23	-29	-19	-7	6	6	19	18	-21	-19
Liabilities And Stockholders Equity	248	221	226	219	229	213	233	230	234	226	189	168
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	-	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Outstanding	-	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Shares Outstanding	66	66	65	65	65	64	63	63	63	62	58	57

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	17.56%	27.78%	7.17%	-	-	-	-	-	-	-	-	-
2025	-21.85%	-22.28%	-18.96%	-14.37%	-32.77%	-23.79%	5.14%	1.32%	-27.75%	-2.91%	28.33%	47.46%
2024	-3.65%	-19.15%	-8.27%	27.70%	33.25%	33.82%	-18.56%	-34.03%	-15.35%	-16.03%	-18.82%	-32.54%
2023	-	-	-	-	-	-	20.67%	30.32%	47.77%	-5.34%	-22.72%	-15.42%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.70	2.04	1.90	2.02	2.27	2.34	2.40	2.47	2.92	3.21	2.33	1.90
Quick Ratio	1.24	1.61	1.49	1.46	1.78	2.10	2.16	2.17	2.57	2.84	1.98	1.46
Working Capital	68.81M	70.90M	67.61M	68.18M	81.22M	75.49M	88.38M	89.55M	104.02M	103.46M	64.13M	43.46M
Leverage & Debt
Debt to Equity	-9.03	-8.67	-10.78	-8.61	-13.27	-33.31	41.12	37.98	11.10	11.26	-10.14	-9.67
Interest Coverage TTM	-1.15	-1.26	-1.66	-1.93	-2.06	-2.20	-1.84	-2.23	-2.24	-2.93	-3.56	-4.14
Debt Ratio	1.12	1.13	1.10	1.13	1.08	1.03	0.98	0.97	0.92	0.92	1.11	1.12
Efficiency & Turnover
Asset Turnover TTM	1.33	1.39	1.30	1.27	1.20	1.25	1.26	1.25	1.18	1.14	1.10	1.02
Days Sales Outstanding TTM	63.48	60.27	62.87	60.71	59.66	54.12	53.60	55.20	55.49	47.93	47.84	50.76
Receivables Turnover TTM	5.75	6.06	5.81	6.01	6.12	6.74	6.81	6.61	6.58	7.62	7.63	7.19
Per Share Metrics
Diluted EPS TTM	-0.52	-0.67	-0.80	-0.90	-0.96	-0.88	-0.81	-0.88	-0.85	-1.02	-1.08	-1.11
Free Cash Flow Per Share TTM	-0.37	-0.62	-0.71	-0.57	-0.42	-0.39	-0.31	-0.37	-0.29	-0.42	-0.61	-0.78
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	66.74%	66.06%	66.33%	66.63%	67.18%	68.41%	68.46%	67.83%	67.83%	67.59%	68.08%	69.87%
Operating Profit Margin TTM	-5.90%	-8.06%	-10.99%	-13.71%	-15.53%	-14.76%	-12.92%	-16.40%	-16.31%	-20.99%	-24.36%	-27.73%
Net Profit Margin TTM	-10.85%	-14.39%	-17.38%	-20.49%	-22.31%	-20.40%	-18.94%	-22.33%	-22.43%	-27.31%	-30.52%	-34.11%
Growth Metrics
Net Revenue Growth (1Y)	13.87%	9.56%	11.61%	15.10%	17.15%	25.38%	31.76%	34.43%	40.71%	40.45%	35.98%	32.30%
Net Income Growth (1Y)	-44.62%	-22.74%	2.42%	5.59%	16.50%	-6.33%	-18.26%	-11.99%	-19.82%	-16.32%	-17.10%	-20.66%
EPS Growth (1Y)	-45.79%	-24.51%	-1.47%	3.02%	13.23%	-13.54%	-24.98%	-20.53%	-27.24%	-19.62%	-18.35%	-21.83%
Valuation Metrics
P/E TTM	-13.33	-6.17	-8.30	-6.79	-9.59	-13.63	-13.58	-18.45	-12.79	-13.72	-9.72	-8.27
P/B TTM	-14.81	-9.31	-18.55	-13.82	-31.87	-116.03	123.99	173.69	35.24	44.63	-28.97	-26.91
P/S TTM	1.45	0.89	1.44	1.39	2.14	2.78	2.57	4.12	2.87	3.75	2.97	2.82
Market Cap	457.55M	267.92M	428.72M	397.42M	594.41M	766.27M	684.67M	1.02B	680.56M	823.16M	599.35M	521.19M
Enterprise Value	569.12M	374.54M	520.99M	499.68M	678.14M	820.18M	719.22M	1.06B	707.81M	846.84M	656.88M	577.60M
Calculated Values
Free Cash Flow TTM	-24.59M	-40.12M	-45.71M	-36.73M	-27.14M	-24.55M	-19.47M	-23.24M	-18.16M	-24.54M	-34.48M	-44.73M
Net Debt	111.57M	106.62M	92.27M	102.26M	83.74M	53.91M	34.55M	36.17M	27.25M	23.68M	57.52M	56.41M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-20Sale

Owner: Moatazedi, David

Title: See Remarks

Shares: 13,669

Price/Share: $4.75

Value: $64,927.75

Shares Owned: 604,700

Relationship: Director,Officer

Ownership: Direct

2026-03-20Sale

Owner: Avelar, Rui

Title: See Remarks

Shares: 3,119

Price/Share: $4.75

Value: $14,815.25

Shares Owned: 427,423

Relationship: Officer

Ownership: Direct

2026-03-17Sale

Owner: Avelar, Rui

Title: See Remarks

Shares: 29,996

Price/Share: $4.89

Value: $146,680.44

Shares Owned: 430,542

Relationship: Officer

Ownership: Direct

2026-03-17Sale

Owner: Moatazedi, David

Title: See Remarks

Shares: 116,720

Price/Share: $4.89

Value: $570,760.80

Shares Owned: 618,369

Relationship: Director,Officer

Ownership: Direct

2025-12-22Sale

Owner: Avelar, Rui

Title: See Remarks

Shares: 2,261

Price/Share: $7.15

Value: $16,166.15

Shares Owned: 356,821

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-20	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	13,669	4.75	$64,927.75	604,700	4
2026-03-20	Avelar, Rui	Officer	See Remarks	Direct	Sale	3,119	4.75	$14,815.25	427,423	4
2026-03-17	Avelar, Rui	Officer	See Remarks	Direct	Sale	29,996	4.89	$146,680.44	430,542	4
2026-03-17	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	116,720	4.89	$570,760.80	618,369	4
2025-12-22	Avelar, Rui	Officer	See Remarks	Direct	Sale	2,261	7.15	$16,166.15	356,821	4
2025-12-22	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	10,539	7.15	$75,353.85	354,388	4
2025-08-22	Yamagishi-Dressler, Tomok…	Officer	Chief Marketing Officer	Direct	Sale	5,722	7.51	$42,972.22	89,949	4
2025-08-15	Stewart, Brady	Director	-	Direct	Purchase	30,000	6.82	$204,600.00	88,629	4
2025-06-16	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	16,582	9.89	$163,995.98	364,927	4
2025-06-09	White, Albert G Iii	Director	-	Direct	Purchase	20,000	9.45	$189,000.00	50,378	4
2025-05-13	Beaver, Sandra	Officer	Chief Financial Officer	Direct	Sale	6,494	10.02	$65,069.88	167,089	4
2025-05-12	Avelar, Rui	Officer	See Remarks	Direct	Sale	3,385	9.87	$33,409.95	359,082	4
2025-05-12	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	15,787	9.87	$155,817.69	492,832	4
2025-03-27	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	6,251	12.40	$77,512.40	508,619	4
2025-03-18	Beaver, Sandra	Officer	Chief Financial Officer	Direct	Sale	8,996	13.26	$119,286.96	173,583	4
2025-03-18	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	103,376	13.26	$1,370,765.76	514,870	4
2025-03-18	Avelar, Rui	Officer	See Remarks	Direct	Sale	27,904	13.26	$370,007.04	362,467	4
2025-03-18	Yamagishi-Dressler, Tomok…	Officer	Chief Marketing Officer	Direct	Sale	4,536	13.26	$60,147.36	95,671	4
2025-03-12	Parschauer, Karah Herdman	Director	-	Direct	Sale	12,888	12.99	$167,415.12	32,183	4
2024-12-23	Avelar, Rui	Officer	See Remarks	Direct	Sale	2,252	10.85	$24,434.20	366,595	4
2024-12-23	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	10,502	10.85	$113,946.70	522,847	4
2024-12-23	Beaver, Sandra	Officer	Chief Financial Officer	Direct	Sale	1,586	10.85	$17,208.10	146,916	4
2024-09-06	Beaver, Sandra	Officer	Chief Financial Officer	Direct	Sale	3,276	14.98	$49,074.48	148,502	4
2024-08-30	Yamagishi-Dressler, Tomok…	Officer	Chief Marketing Officer	Direct	Sale	5,631	15.85	$89,251.35	82,375	4
2024-06-06	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	175,940	12.59	$2,215,084.60	533,349	4
2024-06-03	Malik, Vikram	Director	-	Direct	Sale	7,500	12.96	$97,200.00	246,514	4
2024-05-14	Gill, David N	Director	-	Direct	Sale	6,718	12.60	$84,646.80	33,964	4
2024-05-13	Malik, Vikram	Director	-	Direct	Sale	28,000	12.93	$362,040.00	254,014	4
2024-05-10	Beaver, Sandra	Officer	Chief Financial Officer	Direct	Sale	2,423	12.72	$30,820.56	151,778	4
2024-05-10	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	16,051	12.72	$204,168.72	673,563	4
2024-05-10	Avelar, Rui	Officer	See Remarks	Direct	Sale	3,441	12.72	$43,769.52	368,847	4
2024-03-27	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	6,236	13.86	$86,430.96	689,614	4
2024-03-19	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	96,566	13.92	$1,344,198.72	695,850	4
2024-03-19	Beaver, Sandra	Officer	Chief Financial Officer	Direct	Sale	5,672	13.92	$78,954.24	154,201	4
2024-03-19	Avelar, Rui	Officer	See Remarks	Direct	Sale	27,603	13.92	$384,233.76	372,288	4
2024-02-22	Avelar, Rui	Officer	See Remarks	Direct	Sale	1,821	13.08	$23,818.68	399,891	4
2024-02-22	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	7,706	13.08	$100,794.48	792,416	4
2024-02-22	Beaver, Sandra	Officer	Chief Financial Officer	Direct	Sale	1,821	13.08	$23,818.68	159,873	4
2024-01-30	Parschauer, Karah Herdman	Director	-	Direct	Sale	11,931	13.14	$156,773.34	31,243	4
2023-12-08	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	31,300	9.73	$304,549.00	603,944	4
2023-10-16	Medytox, Inc.	Other	-	Direct	Sale	1,690,663	7.50	$12,679,972.50	3,381,326	4
2023-09-06	Beaver, Sandra	Officer	Chief Financial Officer	Direct	Sale	3,178	9.70	$30,826.60	113,368	4
2023-08-16	Avelar, Rui	Officer	See Remarks	Direct	Sale	2,211	10.27	$22,706.97	353,386	4
2023-08-16	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	14,778	10.27	$151,770.06	686,592	4
2023-08-16	Beaver, Sandra	Officer	Chief Financial Officer	Direct	Sale	2,211	10.27	$22,706.97	116,546	4
2023-08-15	Malik, Vikram	Director	-	Direct	Purchase	174,967	7.41	$1,296,505.47	275,550	4
2023-03-27	Moatazedi, David	Director,Officer	See Remarks	Direct	Sale	6,110	8.47	$51,751.70	609,567	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

69.57%

Inst. Shares: 45,351,803

Shares Outstanding: 65,186,643

2025-12-31

74.82%

Inst. Shares: 48,236,321

Shares Outstanding: 64,468,913

2025-09-30

83.74%

Inst. Shares: 54,201,450

Shares Outstanding: 64,726,239

2025-06-30

89.69%

Inst. Shares: 57,882,131

Shares Outstanding: 64,539,291

2025-03-31

83.71%

Inst. Shares: 53,320,441

Shares Outstanding: 63,696,627

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	45,351,803	65,186,643	69.57%
2025-12-31	48,236,321	64,468,913	74.82%
2025-09-30	54,201,450	64,726,239	83.74%
2025-06-30	57,882,131	64,539,291	89.69%
2025-03-31	53,320,441	63,696,627	83.71%
2024-12-31	51,131,022	62,016,853	82.45%
2024-09-30	48,803,619	63,148,968	77.28%
2024-06-30	50,232,755	62,724,604	80.08%
2024-03-31	48,203,647	58,797,311	81.98%
2023-12-31	44,882,134	56,918,721	78.85%
2023-09-30	40,989,564	57,023,151	71.88%
2023-06-30	36,249,276	56,920,260	63.68%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Evolus, Inc. (EOLS) — SEC Financial Statements & Analysis

Evolus, Inc. (EOLS) is a pharmaceutical preparations company, incorporated in DE. Evolus, Inc. trades on Nasdaq as: EOLS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Evolus, Inc. reported a 13.87% year-over-year revenue growth, a Gross Profit Margin of 66.74% (TTM), a Debt-to-Equity ratio of -9.03x, a Price-to-Sales (P/S) ratio of 1.45x (TTM), a Price-to-Book (P/B) ratio of -14.81x (TTM), at a market cap of $457.55M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 13.87%
Gross Profit Margin TTM: 66.74%
Debt To Equity: -9.03x
P/S TTM: 1.45x
P/B TTM: -14.81x
Market Cap: $457.55M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Evolus, Inc. in?

Evolus, Inc. (EOLS) operates in the Pharmaceutical Preparations industry.

What is EOLS's market cap?

Evolus, Inc. (EOLS) has a market capitalization of $457.55M as of 2026-06-30.

What exchange does EOLS trade on?

Evolus, Inc. (EOLS) trades on the Nasdaq.

Where is Evolus, Inc. incorporated?

Evolus, Inc. is incorporated in DE.

Evolus, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Evolus, Inc. (EOLS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Evolus, Inc. (EOLS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.